AHI — Advanced Health Intelligence Share Price
Last trade - 00:00- $12.85m
- $12.66m
- AU$2.79m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 32.32 | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 9.88 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 7.18 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -376.24% | ||
| Return on Equity | -242.4% | ||
| Operating Margin | -388.32% | ||
Financial Summary
| Year End 30th Jun | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | AU$m | 0.9 | 0.67 | 1.24 | 0.6 | 2.79 | 16 | 75 | 6.04% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | +100 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Advanced Health Intelligence Limited is an Australia-based company that provides biometric-derived digital healthcare solutions. The Company’s products include Biometric Health Assessment (BHA), FaceScan, and BodyScan. Its BHA delivers preventative healthcare measures and refines risk stratification across populations. Its comprehensive insights cover a range of health vitals and risk predictions, allowing its partners to guide individuals into personalized stepped-care pathways. This includes connecting high-risk individuals to traditional primary care, telehealth, or e-health programs. FaceScan estimates vital signs and predicts the risk of chronic disease on a smartphone or Web browser. FaceScan provides estimated readings on heart rate, respiration rate, blood pressure and more in 30 seconds or less. BodyScan is optimized to run on-device using only a smartphone, to deliver accurate body dimension and composition estimates in 60 seconds or less.
Directors
- Vlado Bosanac CHM
- Steven Richards CFO
- Anita Swan DMK
- William Bradford OTH
- Amar El-Sallam OTH
- Dato Low Koon Poh NED
- Michael Melby NED
- Nick Prosser NED
- Edward Greissing NID (70)
- Last Annual
- June 30th, 2023
- Last Interim
- June 30th, 2023
- Incorporated
- October 1st, 2014
- Public Since
- August 17th, 2015
- No. of Shareholders
- 4,289
- Sector
- Software & IT Services
- Industry
- Technology
- Exchange
- NASDAQ Capital Market
- Shares in Issue
- 217,703,969
- Address
- Unit 5, 71-73 South Perth Esplanade, PERTH, 6151
- Web
- https://www.ahi.tech/
- Phone
- +61 893169100
- Auditors
- PKF Brisbane Audit
Similar to AHI
Abits
NASDAQ Capital Market
Ads-Tec Energy
NASDAQ Capital Market
AdTheorent Holding
NASDAQ Capital Market
AGM group
NASDAQ Capital Market
Akso Health
NASDAQ Capital Market
FAQ
As of Today at 19:00 UTC, shares in Advanced Health Intelligence are trading at $1.50. This share price information is delayed by 15 minutes.
Shares in Advanced Health Intelligence last closed at $1.50 and the price had moved by +211.85% over the past 365 days. In terms of relative price strength the Advanced Health Intelligence share price has outperformed the S&P500 Index by +159.51% over the past year.
The overall consensus recommendation for Advanced Health Intelligence is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Advanced Health Intelligence does not currently pay a dividend.
Advanced Health Intelligence does not currently pay a dividend.
Advanced Health Intelligence does not currently pay a dividend.
To buy shares in Advanced Health Intelligence you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $1.50, shares in Advanced Health Intelligence had a market capitalisation of $12.85m.
Here are the trading details for Advanced Health Intelligence:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: AHI
Based on an overall assessment of its quality, value and momentum Advanced Health Intelligence is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Advanced Health Intelligence is $7.70. That is 413.36% above the last closing price of $1.50.
Analysts covering Advanced Health Intelligence currently have a consensus Earnings Per Share (EPS) forecast of AU$0.04 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Advanced Health Intelligence. Over the past six months, its share price has underperformed the S&P500 Index by -70.18%.
As of the last closing price of $1.50, shares in Advanced Health Intelligence were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Advanced Health Intelligence PE ratio based on its reported earnings over the past 12 months is 32.32. The shares last closed at $1.50.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Advanced Health Intelligence's management team is headed by:
- Vlado Bosanac - CHM
- Steven Richards - CFO
- Anita Swan - DMK
- William Bradford - OTH
- Amar El-Sallam - OTH
- Dato Low Koon Poh - NED
- Michael Melby - NED
- Nick Prosser - NED
- Edward Greissing - NID